GVR Report cover Small Animal Imaging (In-vivo) Market Size, Share & Trends Report

Small Animal Imaging (In-vivo) Market Size, Share & Trends Analysis Report By Technology (Optical Imaging, Micro-Magnetic Resonance Imaging, Nuclear Imaging), By Application, And Segment Forecasts, 2012 - 2022

  • Report ID: 978-1-68038-645-5
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2012 - 2013
  • Industry: Healthcare

Industry Outlook

The global small animal imaging (in-vivo) market size was estimated at USD 1.61 billion in 2016. It is expected to rise at a CAGR of 9.0% during the forecast period. A varied range of devices is used in various domains such as monitoring drug response during drug development, evaluating the bio-distribution patterns of new molecules, and cancer cell research.

North America Small Animal Imaging (In-vivo) Market

Different types of in-vivo modalities are used in small animal imaging operations. These modalities are gaining significant importance and find applications in defining mechanisms of action, receptor targeting, and epigenetic research studies.

The ongoing evolution of technology witnesses rapid growth in the development and use of multimodal instruments, both in the preclinical and clinical phases. Dual-modality or hybrid PET/CT scanners are preferred systems for clinical nuclear medicines; in addition, SPECT/CT scanners are also now widely used for routine analysis. The advantage of these multimodal instruments is derived from combining the functional strength of one technology, such as SPECT and PET, with the high-resolution anatomical imaging offered by CT or MRI. PET/CT, PET/MRI, and SPECT/CT are the recent technological advancements in preclinical in-vivo modalities.

These non-invasive modalities allow functional, structural, and molecular imaging of subjects. It is projected that the growing use of molecular imaging in medicine and biology would drive the development of novel instruments as well as refinement of current technologies. The objective of molecular imaging is to characterize, visualize, and quantify normal and pathological biological activities in living organisms at sub-cellular and cellular levels using noninvasive methods.

Technological advancements are playing a critical role in the growth of the market. For instance, Aspect Imaging launched M2 3D MR-based histology system for in-vivo and ex-vivo toxicological imaging. The M2 3D MR-based histology system is a compact, multimodal, and high-resolution MRI instrument for high-throughput in-vivo and ex-vivo imaging of preclinical subjects. The M2 provides a wide range of benefits of MRI including high-resolution 3D images of internal, and anatomical morphology, and quantitative information regarding disease progression and regression.

Technical innovations such as high-resolution MRI with other modalities and a growing number of pharmaceutical & research organizations are among the key trends stimulating market growth. Increasing investments of CROs in preclinical studies and rising usage of multi-functional pre-clinical imaging are poised to provide a fillip to the market. On the other hand, the high cost of devices, inadequate reimbursement policies, and stringent government regulations are some of the factors that are anticipated to restrain the growth of the market.

Technology Insights

On the basis of technology, the small animal imaging (in-vivo) market is segmented into micro-MRI, optical, nuclear imaging, and others, including micro-CT and micro-ultrasound. Optical imaging was the largest segment in terms of revenue in 2016 owing to its rapid and easy operations and better cost-effectiveness as compared to other modalities. Micro-MRI technology is likely to register the highest CAGR over the forecast period due to its advantages such as precise and specific operations, which help in delivering improved results in preclinical research.

Application Insights

On the basis of application, the market is divided into monitoring treatment response, bio-distribution, cancer cell detection, biomarkers, longitudinal studies, and epigenetic studies segments. Bio-distribution and monitoring the treatment response are the two largest application segments. Bio-distribution was the largest segment in 2014 and is estimated to show the same trend over the forecast period.

Global Small Animal Imaging (In-vivo) Market

Drug-target engagement assessment of new molecules or preclinical bio-distribution is critical in determining drug efficacy to optimize drug formulations and find suitable profiles. Noninvasive near infrared (NIR) fluorescence imaging provides visualization and detection of full body tissue bio-distribution of a new drug in real-time.

However, the cancer cell detection segment is expected to show the fastest growth due to the growing global prevalence of cancer, which will provide research opportunities to market players. The cancer cell detection application is projected to capture a substantial market share by 2022.

Regional Insights

North America was the largest revenue contributor in 2014. The growth of the market in the region can be attributed to innovative modality innovations resulting from technological advancements. Varied preclinical research across the region is poised to help the market gain tremendous momentum during the forecast period.

Europe is anticipated to be the second largest market during the forecast period owing to the presence of a large number of diagnostic device manufacturers, clinical research, and pharmaceutical organizations. The Asia Pacific is likely to witness the fastest growth over the forecast period, owing to the transition of clinical research activities from developed to developing countries.

Small Animal Imaging (In-vivo) Market Share Insights

Some of the key players mentioned in the report are Promega Corporation, Inc.; Miltenyi Biotec GmbH; Life Technologies Corporation; FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd. Players are adopting different marketing strategies to increase their market shares and to expand their geographic presence by mergers & acquisition and new product launch.

Report Scope



Base year for estimation


Actual estimates/Historical data

2012 - 2013

Forecast period

2015 - 2022

Market representation

Revenue in USD Million & CAGR from 2015 to 2022

Regional scope

North America, Europe, Asia Pacific, RoW

Report coverage      

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global small animal imaging (in-vivo) market report on the basis of technology, application, and region:

  • Technology Outlook (Revenue, USD Million, 2012 - 2022)

    • Micro-magnetic resonance imaging

    • Optical imaging

    • Nuclear imaging

    • Other imaging modalities

  • Application Outlook (Revenue, USD Million, 2012 - 2022)

    • Monitoring treatment response

    • Bio-distribution, determining drug/target engagement

    • Cancer cell detection

    • Biomarkers

    • Longitudinal studies

    • Epigenetics

  • Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • North America

    • Europe

    • Asia Pacific

    • RoW

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.